Avalair

Avalair Dosage/Direction for Use

montelukast

Manufacturer:

Nano Medic Care

Distributor:

Apex
Full Prescribing Info
Dosage/Direction for Use
Montelukast should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualized to suit patient needs.
Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.
The dosage for pediatric in patients 2 to 5 years of age is one 4mg chewable tablet daily.
Pediatric Patients 12 months to 2 Years of Age with Asthma: The dosage for pediatric patients 12 months to 2 years of age is one packet of 4mg oral granules once daily.
General Recommendations: The therapeutic effect of montelukast on parameters of asthma control occurs within one day. Montelukast chewable tablets can be taken with or without food. Patients should be advised to continue taking Montelukast while their asthma is controlled, as well as during periods of worsening asthma.
No dosage adjustment is necessary for pediatric patients, for the elderly, for patients with renal insufficiency, or mild-to-moderate hepatic impairment, or for patients of either gender.
Montelukast is a long term-controller medication which should not be substituted for short acting beta-agonists. It is effective alone or in combination with other prophylactic agent.
Montelukast is a preventive agent, which should be used in addition to other drugs for the management of asthma.
Therapy with Montelukast in Relation to Other Treatments for Asthma Montelukast can be added to a patient's existing treatment regimen.
Reduction in Concomitant Therapy: Bronchodilator Treatments: Montelukast can be added to the treatment regimen of patients who are not adequately controlled on bronchodilator alone. When a clinical response is evident (usually after the first dose), the patient's bronchodilator therapy can be reduced as tolerated.
Inhaled Corticosteroids: Treatment with Montelukast provides additional clinical benefit to patients treated with inhaled corticosteroids. A reduction in the corticosteroid dose can be made as tolerated. The dose should be reduced gradually with medical supervision. In some patients, the dose of inhaled corticosteroids can be tapered off completely.
Montelukast should not be abruptly substituted for inhaled corticosteroids.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in